While the proportions of both CD4+ T cells and CD8+ T cells were not altered by the therapy (Supplemental Figure 9B), the expression of ICOS in peripheral CD4+ T cells was significantly upregulated in patients with the irAE pneumonitis, but not in those without any irAEs (Figure 7, A and B). The gene discussed is CD8A; the disease is pneumonitis.